Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1200/OP.20.00894 http://scihub22266oqcxt.onion/10.1200/OP.20.00894 33529059!8457796!33529059     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       JCO+Oncol+Pract 2021 ; 17 (9): 541-545 Nephropedia Template TP {{tp|p=33529059|t=2021. Dana-Farber Cancer Institute/Mass General Brigham Fellowship Response to the COVID-19 Pandemic |pdf=|usr=}}{{33529059}} gab.com Text Dana-Farber Cancer Institute/Mass General Brigham Fellowship Response to the COVID-19 Pandemic JO: JCO Oncol Pract http://www.kidney.de/pget.php?&tw=1&pmid=33529059 #FOAvip The coronavirus disease (COVID)-19 pandemic has affected graduate medical education training programs, including hematology-oncology fellowship programs, both across the United States and abroad. Within the Dana-Farber Cancer Institute/Mass General Brigham hematology-oncology fellowship program, fellowship leadership had to quickly reorganize the program's clinical, educational, and research structure to minimize the risk of COVID-19 spread to our patients and staff, allow fellows to assist in the care of patients with COVID-19, maintain formal didactics despite physical distancing, and ensure the mental and physical well-being of fellows. Following the first wave of patients with COVID-19, we anonymously surveyed the Dana-Farber Cancer Institute/Mass General Brigham first-year fellows to explore their perceptions regarding what the program did well and what could have been improved in the COVID-19 response. In this article, we present the feedback from our fellows and the lessons we learned as a program from this feedback. To our knowledge, this represents the first effort in the hematology-oncology literature to directly assess a hematology-oncology program's overall response to COVID-19 through direct feedback from fellows. Twit Text FOAVip Dana-Farber Cancer Institute/Mass General Brigham Fellowship Response to the COVID-19 Pandemic ????JCO Oncol Pract http://www.kidney.de/pget.php?&tw=1&pmid=33529059 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33529059 #FOAvip English Wikipedia <ref>{{Cite pmid|33529059}}</ref> Dana-Farber Cancer Institute/Mass General Brigham Fellowship Response to the COVID-19 Pandemic #MMPMID33529059 Stern RM; Michaelson MD; Mayer EL; Parnes AD; Fogerty AE; LaCasce AS; Nipp RD JCO Oncol Pract 2021[Sep]; 17 (9): 541-545 PMID33529059show ga The coronavirus disease (COVID)-19 pandemic has affected graduate medical education training programs, including hematology-oncology fellowship programs, both across the United States and abroad. Within the Dana-Farber Cancer Institute/Mass General Brigham hematology-oncology fellowship program, fellowship leadership had to quickly reorganize the program's clinical, educational, and research structure to minimize the risk of COVID-19 spread to our patients and staff, allow fellows to assist in the care of patients with COVID-19, maintain formal didactics despite physical distancing, and ensure the mental and physical well-being of fellows. Following the first wave of patients with COVID-19, we anonymously surveyed the Dana-Farber Cancer Institute/Mass General Brigham first-year fellows to explore their perceptions regarding what the program did well and what could have been improved in the COVID-19 response. In this article, we present the feedback from our fellows and the lessons we learned as a program from this feedback. To our knowledge, this represents the first effort in the hematology-oncology literature to directly assess a hematology-oncology program's overall response to COVID-19 through direct feedback from fellows. |*COVID-19[MESH] |*Hematology[MESH] |*Neoplasms[MESH] |Fellowships and Scholarships[MESH] |Humans[MESH] |Pandemics[MESH] |SARS-CoV-2[MESH]Dana-Farber Cancer Institute/Mass General Brigham Fellowship Response (epmc).pdf DeepDyve Pubget Overpricing